Frontiers in Public Health (Jul 2022)
Spending and Hospital Stay for Melanoma in Hunan, China
- Xinchen Ke,
- Xinchen Ke,
- Xinchen Ke,
- Xinchen Ke,
- Wenrui Lin,
- Wenrui Lin,
- Wenrui Lin,
- Wenrui Lin,
- Daishi Li,
- Daishi Li,
- Daishi Li,
- Daishi Li,
- Shuang Zhao,
- Shuang Zhao,
- Shuang Zhao,
- Shuang Zhao,
- Mingliang Chen,
- Mingliang Chen,
- Mingliang Chen,
- Mingliang Chen,
- Yi Xiao,
- Yi Xiao,
- Yi Xiao,
- Yi Xiao,
- Xiang Chen,
- Xiang Chen,
- Xiang Chen,
- Xiang Chen,
- Minxue Shen,
- Minxue Shen,
- Minxue Shen,
- Minxue Shen,
- Juan Su,
- Juan Su,
- Juan Su,
- Juan Su
Affiliations
- Xinchen Ke
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
- Xinchen Ke
- Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China
- Xinchen Ke
- Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China
- Xinchen Ke
- National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- Wenrui Lin
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
- Wenrui Lin
- Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China
- Wenrui Lin
- Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China
- Wenrui Lin
- National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- Daishi Li
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
- Daishi Li
- Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China
- Daishi Li
- Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China
- Daishi Li
- National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- Shuang Zhao
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
- Shuang Zhao
- Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China
- Shuang Zhao
- Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China
- Shuang Zhao
- National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- Mingliang Chen
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
- Mingliang Chen
- Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China
- Mingliang Chen
- Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China
- Mingliang Chen
- National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- Yi Xiao
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
- Yi Xiao
- Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China
- Yi Xiao
- Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China
- Yi Xiao
- National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- Xiang Chen
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
- Xiang Chen
- Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China
- Xiang Chen
- Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China
- Xiang Chen
- National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- Minxue Shen
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
- Minxue Shen
- Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China
- Minxue Shen
- Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China
- Minxue Shen
- Department of Social Medicine and Health Management, Xiangya School of Public Health, Central South University, Changsha, China
- Juan Su
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
- Juan Su
- Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China
- Juan Su
- Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China
- Juan Su
- National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- DOI
- https://doi.org/10.3389/fpubh.2022.917119
- Journal volume & issue
-
Vol. 10
Abstract
ObjectiveThis study aimed to describe the economic burden of Chinese patients with melanoma in Hunan province of China, and to investigate the factors for hospitalization spending and length of stay (LOS) in patients undergoing melanoma surgery.MethodsData was extracted from the Chinese National Health Statistics Network Reporting System database in Hunan province during 2017–2019. Population and individual statistics were presented, and nonparametric tests and quantile regression were used to analyze the factors for spending and LOS.ResultA total of 2,644 hospitalized patients with melanoma in Hunan were identified. During 2017–2019, the total hospitalization spending was $5,247,972, and out-of-pocket payment (OOP) was $1,817,869, accounting for 34.6% of the total expenditure. The median spending was $1,123 [interquartile range (IQR): $555–2,411] per capita, and the median LOS was 10 days (IQR: 5–18). A total of 1,104 patients who underwent surgery were further analyzed. The non-parametric tests and quantile regression showed that women were associated with less spending and LOS than men. In general, patients aged 46–65 and those with lesions on the limbs had higher hospitalization costs and LOS than other subgroups.ConclusionMelanoma causes heavy economic burdens on patients in Hunan, such that the median spending is close to 60% of the averagely annual disposable income. Middle-aged men patients with melanoma on the limbs present the highest financial burden of melanoma.
Keywords
